|
Thank You that is very helpful information. Ruxolitinib was reccomended just before she went into the hospital. We are still waiting on insurance information. It may be prohivitively expensive. We are also concerned that it may not be safe to risk the myelosuppression due to her low platelets. I guess that is why I feel like we are reaching the end of the road. I will continue to investigate the Ruxolitinib though.
|